Table 2.

Association between miR‐1 ISH status and clinicopathological parameters in 163 breast carcinomas

Variable	miR‐1 status		P‐value
	+ (n = 32)	− (n = 131)
Agea(years)	56.5 ± 2.1	56.3 ± 1.1	0.93
Menopausal status
Premenopausal	12	49
Postmenopausal	20	82	0.76
Stage
I	3	65
II	7	41
III	8	17
IV	14	8	<0.0001
Pathological T factor (pT)
pT1	5	80
pT2‐4	27	51	<0.0001
Lymph node metastasis
Positive	24	49
Negative	8	82	0.0001
Distant metastasis
Positive	14	8
Negative	18	123	<0.0001
Histological grade
1 (well)	5	42
2 (moderate)	10	60
3 (poor)	17	29	<0.0001
ER status
Positive	19	106
Negative	13	25	0.0098
PR status
Positive	14	92
Negative	18	39	0.0049
HER2 status
Positive	6	21
Negative	26	110	0.71
Ki‐67 LIa (%)	26.8 ± 4.0	14.4 ± 1.1	<0.0001

^aData are presented as mean ± SEM. All other values represent the number of cases P‐values < 0.05 were considered significant, and are presented in bold.